Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DYN
DYN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DYN News
Dyne vs Recursion: Biotechnology Investment Choices
4d ago
NASDAQ.COM
Investment Comparison: Dyne vs Recursion
4d ago
Fool
Investment Comparison: Dyne vs. Vertex Pharmaceuticals
Jul 01 2026
Fool
Clinical Trials Shape 2026 for Dyne and Viking
Jun 26 2026
Fool
Comparative Analysis of Dyne and Viking Biotech Companies
Jun 26 2026
NASDAQ.COM
Dyne Therapeutics Appoints Barry Greene to Board of Directors
Jun 23 2026
NASDAQ.COM
Dyne Therapeutics Expands Debt Facility to $400M with Hercules Capital
Jun 17 2026
seekingalpha
Dyne Therapeutics Secures $125 Million in Additional Financing
Jun 17 2026
Newsfilter
Dyne Therapeutics Completes Enrollment in DM1 Trial Expansion Cohort
Jun 03 2026
Newsfilter
FCPM III Services B.V. Reduces Stake in Dyne Therapeutics
May 30 2026
Fool
FCPM III Reduces Stake in Dyne Therapeutics by $14 Million
May 30 2026
Yahoo Finance
Dyne Therapeutics Submits BLA for DMD Treatment Z-rostudirsen
May 27 2026
NASDAQ.COM
Dyne Therapeutics Submits BLA for Accelerated Approval of z-rostudirsen
May 26 2026
Newsfilter
Dyne Therapeutics Grants Inducement Equity Awards to New Employees
May 20 2026
Newsfilter
Dyne Therapeutics Initiates Late-Stage DMD Trial for z-rostudirsen
May 20 2026
stocktwits
Dyne Therapeutics Launches Late-Stage Trial for DMD Therapy
May 20 2026
seekingalpha
Show More News
